nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—lung cancer	0.353	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—lung cancer	0.0738	0.173	CbGbCtD
Foscarnet—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.000249	0.153	CbGpPWpGaD
Foscarnet—Feeling abnormal—Gemcitabine—lung cancer	0.000237	0.000414	CcSEcCtD
Foscarnet—Dizziness—Vinorelbine—lung cancer	0.000237	0.000414	CcSEcCtD
Foscarnet—Hypokalaemia—Doxorubicin—lung cancer	0.000236	0.000412	CcSEcCtD
Foscarnet—Thrombocytopenia—Paclitaxel—lung cancer	0.000236	0.000412	CcSEcCtD
Foscarnet—Anorexia—Etoposide—lung cancer	0.000234	0.000409	CcSEcCtD
Foscarnet—Body temperature increased—Irinotecan—lung cancer	0.000233	0.000408	CcSEcCtD
Foscarnet—Abdominal pain—Irinotecan—lung cancer	0.000233	0.000408	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000233	0.000408	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000233	0.000408	CcSEcCtD
Foscarnet—Decreased appetite—Cisplatin—lung cancer	0.000233	0.000407	CcSEcCtD
Foscarnet—Hyperhidrosis—Paclitaxel—lung cancer	0.000233	0.000407	CcSEcCtD
Foscarnet—Anaemia—Docetaxel—lung cancer	0.000231	0.000404	CcSEcCtD
Foscarnet—Anorexia—Paclitaxel—lung cancer	0.000229	0.000401	CcSEcCtD
Foscarnet—Hypotension—Etoposide—lung cancer	0.000229	0.000401	CcSEcCtD
Foscarnet—Pain—Cisplatin—lung cancer	0.000229	0.000401	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000229	0.0004	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000228	0.0004	CcSEcCtD
Foscarnet—Muscular weakness—Doxorubicin—lung cancer	0.000228	0.0004	CcSEcCtD
Foscarnet—Vomiting—Vinorelbine—lung cancer	0.000228	0.000398	CcSEcCtD
Foscarnet—Body temperature increased—Gemcitabine—lung cancer	0.000227	0.000398	CcSEcCtD
Foscarnet—Renal failure—Methotrexate—lung cancer	0.000227	0.000396	CcSEcCtD
Foscarnet—Rash—Vinorelbine—lung cancer	0.000226	0.000395	CcSEcCtD
Foscarnet—Dermatitis—Vinorelbine—lung cancer	0.000225	0.000394	CcSEcCtD
Foscarnet—Hypotension—Paclitaxel—lung cancer	0.000225	0.000393	CcSEcCtD
Foscarnet—Headache—Vinorelbine—lung cancer	0.000224	0.000392	CcSEcCtD
Foscarnet—Conjunctivitis—Methotrexate—lung cancer	0.000224	0.000392	CcSEcCtD
Foscarnet—Dysphagia—Doxorubicin—lung cancer	0.000224	0.000392	CcSEcCtD
Foscarnet—Leukopenia—Docetaxel—lung cancer	0.000224	0.000391	CcSEcCtD
Foscarnet—Palpitations—Docetaxel—lung cancer	0.000221	0.000386	CcSEcCtD
Foscarnet—Feeling abnormal—Cisplatin—lung cancer	0.000221	0.000386	CcSEcCtD
Foscarnet—Paraesthesia—Etoposide—lung cancer	0.00022	0.000386	CcSEcCtD
Foscarnet—Haematuria—Methotrexate—lung cancer	0.00022	0.000385	CcSEcCtD
Foscarnet—Pancreatitis—Doxorubicin—lung cancer	0.00022	0.000384	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000219	0.000384	CcSEcCtD
Foscarnet—Dyspnoea—Etoposide—lung cancer	0.000219	0.000383	CcSEcCtD
Foscarnet—Somnolence—Etoposide—lung cancer	0.000218	0.000382	CcSEcCtD
Foscarnet—Cough—Docetaxel—lung cancer	0.000218	0.000382	CcSEcCtD
Foscarnet—Insomnia—Paclitaxel—lung cancer	0.000218	0.000381	CcSEcCtD
Foscarnet—Convulsion—Docetaxel—lung cancer	0.000217	0.000379	CcSEcCtD
Foscarnet—Paraesthesia—Paclitaxel—lung cancer	0.000216	0.000378	CcSEcCtD
Foscarnet—Hypertension—Docetaxel—lung cancer	0.000216	0.000378	CcSEcCtD
Foscarnet—Agranulocytosis—Methotrexate—lung cancer	0.000215	0.000376	CcSEcCtD
Foscarnet—Dyspnoea—Paclitaxel—lung cancer	0.000215	0.000375	CcSEcCtD
Foscarnet—Somnolence—Paclitaxel—lung cancer	0.000214	0.000374	CcSEcCtD
Foscarnet—Decreased appetite—Etoposide—lung cancer	0.000213	0.000373	CcSEcCtD
Foscarnet—Arthralgia—Docetaxel—lung cancer	0.000213	0.000372	CcSEcCtD
Foscarnet—Myalgia—Docetaxel—lung cancer	0.000213	0.000372	CcSEcCtD
Foscarnet—Chest pain—Docetaxel—lung cancer	0.000213	0.000372	CcSEcCtD
Foscarnet—Pancytopenia—Doxorubicin—lung cancer	0.000213	0.000372	CcSEcCtD
Foscarnet—Nausea—Vinorelbine—lung cancer	0.000213	0.000372	CcSEcCtD
Foscarnet—Dyspepsia—Paclitaxel—lung cancer	0.000212	0.000371	CcSEcCtD
Foscarnet—Body temperature increased—Cisplatin—lung cancer	0.000212	0.000371	CcSEcCtD
Foscarnet—Asthenia—Irinotecan—lung cancer	0.000212	0.00037	CcSEcCtD
Foscarnet—Fatigue—Etoposide—lung cancer	0.000212	0.00037	CcSEcCtD
Foscarnet—Pain—Etoposide—lung cancer	0.00021	0.000367	CcSEcCtD
Foscarnet—Constipation—Etoposide—lung cancer	0.00021	0.000367	CcSEcCtD
Foscarnet—Dysuria—Doxorubicin—lung cancer	0.000209	0.000366	CcSEcCtD
Foscarnet—Neutropenia—Doxorubicin—lung cancer	0.000209	0.000366	CcSEcCtD
Foscarnet—Decreased appetite—Paclitaxel—lung cancer	0.000209	0.000366	CcSEcCtD
Foscarnet—Dry mouth—Docetaxel—lung cancer	0.000208	0.000364	CcSEcCtD
Foscarnet—Fatigue—Paclitaxel—lung cancer	0.000208	0.000363	CcSEcCtD
Foscarnet—Asthenia—Gemcitabine—lung cancer	0.000206	0.000361	CcSEcCtD
Foscarnet—Constipation—Paclitaxel—lung cancer	0.000206	0.00036	CcSEcCtD
Foscarnet—Pain—Paclitaxel—lung cancer	0.000206	0.00036	CcSEcCtD
Foscarnet—Confusional state—Docetaxel—lung cancer	0.000206	0.00036	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—lung cancer	0.000205	0.000359	CcSEcCtD
Foscarnet—Oedema—Docetaxel—lung cancer	0.000204	0.000357	CcSEcCtD
Foscarnet—Pruritus—Gemcitabine—lung cancer	0.000203	0.000356	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—lung cancer	0.000203	0.000355	CcSEcCtD
Foscarnet—Infection—Docetaxel—lung cancer	0.000203	0.000355	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—lung cancer	0.000203	0.000354	CcSEcCtD
Foscarnet—Feeling abnormal—Etoposide—lung cancer	0.000202	0.000354	CcSEcCtD
Foscarnet—Diarrhoea—Irinotecan—lung cancer	0.000202	0.000353	CcSEcCtD
Foscarnet—Gastrointestinal pain—Etoposide—lung cancer	0.000201	0.000351	CcSEcCtD
Foscarnet—Thrombocytopenia—Docetaxel—lung cancer	0.0002	0.000349	CcSEcCtD
Foscarnet—Feeling abnormal—Paclitaxel—lung cancer	0.000198	0.000347	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000198	0.000346	CcSEcCtD
Foscarnet—Gastrointestinal pain—Paclitaxel—lung cancer	0.000197	0.000344	CcSEcCtD
Foscarnet—Diarrhoea—Gemcitabine—lung cancer	0.000197	0.000344	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—lung cancer	0.000196	0.000343	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—lung cancer	0.000196	0.000342	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—lung cancer	0.000196	0.000342	CcSEcCtD
Foscarnet—Dizziness—Irinotecan—lung cancer	0.000195	0.000341	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—lung cancer	0.000194	0.00034	CcSEcCtD
Foscarnet—Abdominal pain—Etoposide—lung cancer	0.000194	0.000339	CcSEcCtD
Foscarnet—Body temperature increased—Etoposide—lung cancer	0.000194	0.000339	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—lung cancer	0.000194	0.000339	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—lung cancer	0.000194	0.000339	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—lung cancer	0.000193	0.000338	CcSEcCtD
Foscarnet—Asthenia—Cisplatin—lung cancer	0.000192	0.000336	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—lung cancer	0.000191	0.000333	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—lung cancer	0.00019	0.000333	CcSEcCtD
Foscarnet—Abdominal pain—Paclitaxel—lung cancer	0.00019	0.000333	CcSEcCtD
Foscarnet—Body temperature increased—Paclitaxel—lung cancer	0.00019	0.000333	CcSEcCtD
Foscarnet—Vomiting—Irinotecan—lung cancer	0.000188	0.000328	CcSEcCtD
Foscarnet—Sinusitis—Doxorubicin—lung cancer	0.000187	0.000328	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—lung cancer	0.000186	0.000326	CcSEcCtD
Foscarnet—Rash—Irinotecan—lung cancer	0.000186	0.000326	CcSEcCtD
Foscarnet—Dermatitis—Irinotecan—lung cancer	0.000186	0.000325	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000186	0.000325	CcSEcCtD
Foscarnet—Chills—Methotrexate—lung cancer	0.000186	0.000325	CcSEcCtD
Foscarnet—Headache—Irinotecan—lung cancer	0.000185	0.000323	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—lung cancer	0.000185	0.000323	CcSEcCtD
Foscarnet—Diarrhoea—Cisplatin—lung cancer	0.000183	0.000321	CcSEcCtD
Foscarnet—Paraesthesia—Docetaxel—lung cancer	0.000183	0.00032	CcSEcCtD
Foscarnet—Vomiting—Gemcitabine—lung cancer	0.000183	0.00032	CcSEcCtD
Foscarnet—Dyspnoea—Docetaxel—lung cancer	0.000182	0.000318	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—lung cancer	0.000181	0.000317	CcSEcCtD
Foscarnet—Rash—Gemcitabine—lung cancer	0.000181	0.000317	CcSEcCtD
Foscarnet—Dermatitis—Gemcitabine—lung cancer	0.000181	0.000317	CcSEcCtD
Foscarnet—Headache—Gemcitabine—lung cancer	0.00018	0.000315	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—lung cancer	0.00018	0.000314	CcSEcCtD
Foscarnet—Dyspepsia—Docetaxel—lung cancer	0.00018	0.000314	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—lung cancer	0.000178	0.000312	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—lung cancer	0.000178	0.000311	CcSEcCtD
Foscarnet—Decreased appetite—Docetaxel—lung cancer	0.000177	0.00031	CcSEcCtD
Foscarnet—Asthenia—Etoposide—lung cancer	0.000176	0.000308	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—lung cancer	0.000176	0.000308	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—lung cancer	0.000176	0.000307	CcSEcCtD
Foscarnet—Nausea—Irinotecan—lung cancer	0.000175	0.000307	CcSEcCtD
Foscarnet—Constipation—Docetaxel—lung cancer	0.000174	0.000305	CcSEcCtD
Foscarnet—Pain—Docetaxel—lung cancer	0.000174	0.000305	CcSEcCtD
Foscarnet—Back pain—Methotrexate—lung cancer	0.000174	0.000305	CcSEcCtD
Foscarnet—Pruritus—Etoposide—lung cancer	0.000174	0.000304	CcSEcCtD
Foscarnet—Asthenia—Paclitaxel—lung cancer	0.000173	0.000302	CcSEcCtD
Foscarnet—Nausea—Gemcitabine—lung cancer	0.000171	0.000299	CcSEcCtD
Foscarnet—Vomiting—Cisplatin—lung cancer	0.00017	0.000298	CcSEcCtD
Foscarnet—Pruritus—Paclitaxel—lung cancer	0.00017	0.000298	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—lung cancer	0.000169	0.000296	CcSEcCtD
Foscarnet—Rash—Cisplatin—lung cancer	0.000169	0.000296	CcSEcCtD
Foscarnet—Dermatitis—Cisplatin—lung cancer	0.000169	0.000295	CcSEcCtD
Foscarnet—Feeling abnormal—Docetaxel—lung cancer	0.000168	0.000294	CcSEcCtD
Foscarnet—Diarrhoea—Etoposide—lung cancer	0.000168	0.000294	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—lung cancer	0.000167	0.000293	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—lung cancer	0.000167	0.000292	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—lung cancer	0.000167	0.000292	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—lung cancer	0.000167	0.000291	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—lung cancer	0.000166	0.000291	CcSEcCtD
Foscarnet—Diarrhoea—Paclitaxel—lung cancer	0.000165	0.000288	CcSEcCtD
Foscarnet—Malaise—Methotrexate—lung cancer	0.000162	0.000284	CcSEcCtD
Foscarnet—Dizziness—Etoposide—lung cancer	0.000162	0.000284	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—lung cancer	0.000161	0.000282	CcSEcCtD
Foscarnet—Body temperature increased—Docetaxel—lung cancer	0.000161	0.000282	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—lung cancer	0.000161	0.000282	CcSEcCtD
Foscarnet—Chills—Doxorubicin—lung cancer	0.000161	0.000281	CcSEcCtD
Foscarnet—Dizziness—Paclitaxel—lung cancer	0.000159	0.000278	CcSEcCtD
Foscarnet—Nausea—Cisplatin—lung cancer	0.000159	0.000278	CcSEcCtD
Foscarnet—Cough—Methotrexate—lung cancer	0.000157	0.000275	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—lung cancer	0.000156	0.000273	CcSEcCtD
Foscarnet—Vomiting—Etoposide—lung cancer	0.000156	0.000273	CcSEcCtD
Foscarnet—Rash—Etoposide—lung cancer	0.000155	0.000271	CcSEcCtD
Foscarnet—Dermatitis—Etoposide—lung cancer	0.000155	0.000271	CcSEcCtD
Foscarnet—Headache—Etoposide—lung cancer	0.000154	0.000269	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—lung cancer	0.000154	0.000269	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—lung cancer	0.000153	0.000268	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—lung cancer	0.000153	0.000268	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—lung cancer	0.000153	0.000268	CcSEcCtD
Foscarnet—Tension—Doxorubicin—lung cancer	0.000153	0.000268	CcSEcCtD
Foscarnet—Vomiting—Paclitaxel—lung cancer	0.000153	0.000268	CcSEcCtD
Foscarnet—Rash—Paclitaxel—lung cancer	0.000152	0.000265	CcSEcCtD
Foscarnet—Dermatitis—Paclitaxel—lung cancer	0.000152	0.000265	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—lung cancer	0.000152	0.000265	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—lung cancer	0.000152	0.000265	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—lung cancer	0.000151	0.000264	CcSEcCtD
Foscarnet—Headache—Paclitaxel—lung cancer	0.000151	0.000264	CcSEcCtD
Foscarnet—Muscle spasms—Doxorubicin—lung cancer	0.00015	0.000262	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—lung cancer	0.000148	0.000259	CcSEcCtD
Foscarnet—Asthenia—Docetaxel—lung cancer	0.000146	0.000256	CcSEcCtD
Foscarnet—Infection—Methotrexate—lung cancer	0.000146	0.000256	CcSEcCtD
Foscarnet—Nausea—Etoposide—lung cancer	0.000146	0.000255	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—lung cancer	0.000145	0.000253	CcSEcCtD
Foscarnet—Pruritus—Docetaxel—lung cancer	0.000144	0.000252	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—lung cancer	0.000144	0.000252	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—lung cancer	0.000144	0.000252	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—lung cancer	0.000143	0.000251	CcSEcCtD
Foscarnet—Nausea—Paclitaxel—lung cancer	0.000143	0.00025	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—lung cancer	0.000142	0.000249	CcSEcCtD
Foscarnet—Malaise—Doxorubicin—lung cancer	0.000141	0.000246	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—lung cancer	0.00014	0.000245	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—lung cancer	0.00014	0.000244	CcSEcCtD
Foscarnet—Diarrhoea—Docetaxel—lung cancer	0.00014	0.000244	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—lung cancer	0.000138	0.000241	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—lung cancer	0.000137	0.00024	CcSEcCtD
Foscarnet—Cough—Doxorubicin—lung cancer	0.000136	0.000238	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—lung cancer	0.000135	0.000236	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—lung cancer	0.000135	0.000236	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—lung cancer	0.000135	0.000236	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000134	0.000234	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—lung cancer	0.000133	0.000233	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—lung cancer	0.000133	0.000232	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—lung cancer	0.000133	0.000232	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—lung cancer	0.000133	0.000232	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—lung cancer	0.000132	0.000232	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—lung cancer	0.000132	0.000231	CcSEcCtD
Foscarnet—Discomfort—Doxorubicin—lung cancer	0.000131	0.00023	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—lung cancer	0.000131	0.000229	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—lung cancer	0.000131	0.000229	CcSEcCtD
Foscarnet—Dry mouth—Doxorubicin—lung cancer	0.00013	0.000227	CcSEcCtD
Foscarnet—Vomiting—Docetaxel—lung cancer	0.00013	0.000227	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—lung cancer	0.000129	0.000226	CcSEcCtD
Foscarnet—Rash—Docetaxel—lung cancer	0.000129	0.000225	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—lung cancer	0.000129	0.000225	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—lung cancer	0.000128	0.000225	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—lung cancer	0.000128	0.000224	CcSEcCtD
Foscarnet—Headache—Docetaxel—lung cancer	0.000128	0.000224	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—lung cancer	0.000127	0.000223	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—lung cancer	0.000127	0.000222	CcSEcCtD
Foscarnet—Infection—Doxorubicin—lung cancer	0.000126	0.000221	CcSEcCtD
Foscarnet—Pain—Methotrexate—lung cancer	0.000126	0.00022	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—lung cancer	0.000125	0.000218	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—lung cancer	0.000123	0.000215	CcSEcCtD
Foscarnet—Anorexia—Doxorubicin—lung cancer	0.000121	0.000212	CcSEcCtD
Foscarnet—Nausea—Docetaxel—lung cancer	0.000121	0.000212	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—lung cancer	0.000121	0.000212	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—lung cancer	0.00012	0.00021	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—lung cancer	0.000119	0.000208	CcSEcCtD
Foscarnet—SLC16A1—Basigin interactions—PPIA—lung cancer	0.000118	0.0726	CbGpPWpGaD
Foscarnet—Body temperature increased—Methotrexate—lung cancer	0.000116	0.000203	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—lung cancer	0.000116	0.000203	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000116	0.000203	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—lung cancer	0.000115	0.000201	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—lung cancer	0.000114	0.0002	CcSEcCtD
Foscarnet—Dyspnoea—Doxorubicin—lung cancer	0.000114	0.000199	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—lung cancer	0.000113	0.000198	CcSEcCtD
Foscarnet—Dyspepsia—Doxorubicin—lung cancer	0.000112	0.000196	CcSEcCtD
Foscarnet—Decreased appetite—Doxorubicin—lung cancer	0.000111	0.000194	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—lung cancer	0.00011	0.000192	CcSEcCtD
Foscarnet—Pain—Doxorubicin—lung cancer	0.000109	0.00019	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—lung cancer	0.000109	0.00019	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—lung cancer	0.000105	0.000185	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—lung cancer	0.000105	0.000184	CcSEcCtD
Foscarnet—Gastrointestinal pain—Doxorubicin—lung cancer	0.000104	0.000182	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—lung cancer	0.000104	0.000182	CcSEcCtD
Foscarnet—Abdominal pain—Doxorubicin—lung cancer	0.000101	0.000176	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—lung cancer	0.000101	0.000176	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—lung cancer	0.000101	0.000176	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—lung cancer	9.72e-05	0.00017	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—lung cancer	9.35e-05	0.000164	CcSEcCtD
Foscarnet—Rash—Methotrexate—lung cancer	9.27e-05	0.000162	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—lung cancer	9.26e-05	0.000162	CcSEcCtD
Foscarnet—Headache—Methotrexate—lung cancer	9.21e-05	0.000161	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—lung cancer	9.14e-05	0.00016	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—lung cancer	9.01e-05	0.000158	CcSEcCtD
Foscarnet—Nausea—Methotrexate—lung cancer	8.73e-05	0.000153	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—lung cancer	8.71e-05	0.000152	CcSEcCtD
Foscarnet—Dizziness—Doxorubicin—lung cancer	8.42e-05	0.000147	CcSEcCtD
Foscarnet—Vomiting—Doxorubicin—lung cancer	8.1e-05	0.000142	CcSEcCtD
Foscarnet—Rash—Doxorubicin—lung cancer	8.03e-05	0.00014	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—lung cancer	8.02e-05	0.00014	CcSEcCtD
Foscarnet—Headache—Doxorubicin—lung cancer	7.98e-05	0.00014	CcSEcCtD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	7.68e-05	0.0471	CbGpPWpGaD
Foscarnet—Nausea—Doxorubicin—lung cancer	7.56e-05	0.000132	CcSEcCtD
Foscarnet—SLC16A1—Basigin interactions—ITGB1—lung cancer	7.35e-05	0.0451	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—ATP5H—lung cancer	6.76e-05	0.0414	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—MMP1—lung cancer	5.72e-05	0.0351	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	4.98e-05	0.0306	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	4.6e-05	0.0282	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PPIA—lung cancer	3.94e-05	0.0242	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	3.49e-05	0.0214	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	2.99e-05	0.0183	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—lung cancer	2.44e-05	0.015	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	2.34e-05	0.0144	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	2.27e-05	0.0139	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KIF5B—lung cancer	1.97e-05	0.0121	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—MMP1—lung cancer	1.9e-05	0.0117	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	1.77e-05	0.0109	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KDM1A—lung cancer	1.62e-05	0.00993	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	1.52e-05	0.00932	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CD9—lung cancer	1.36e-05	0.00832	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—lung cancer	1.27e-05	0.0078	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AZIN2—lung cancer	1.2e-05	0.00735	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—COL4A3BP—lung cancer	1.2e-05	0.00735	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—FGR—lung cancer	1.18e-05	0.00722	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	1.15e-05	0.00706	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GNG11—lung cancer	1.11e-05	0.00682	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—AVP—lung cancer	1.1e-05	0.00674	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PPIA—lung cancer	1.07e-05	0.00655	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCC3—lung cancer	1.06e-05	0.00652	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFC—lung cancer	1.06e-05	0.0065	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALDOA—lung cancer	1.06e-05	0.0065	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—SRC—lung cancer	1.02e-05	0.00625	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ATP5H—lung cancer	1.02e-05	0.00625	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—NRAS—lung cancer	9.81e-06	0.00601	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PPP2R1B—lung cancer	9.75e-06	0.00598	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—GNG11—lung cancer	9.63e-06	0.00591	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TF—lung cancer	9.3e-06	0.0057	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IRF1—lung cancer	9.1e-06	0.00558	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLBD1—lung cancer	9.08e-06	0.00557	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ADCY1—lung cancer	8.66e-06	0.00531	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCG2—lung cancer	8.66e-06	0.00531	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—lung cancer	8.44e-06	0.00518	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD17B10—lung cancer	8.31e-06	0.00509	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—APP—lung cancer	8.29e-06	0.00508	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—TF—lung cancer	8.05e-06	0.00494	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—lung cancer	7.75e-06	0.00476	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CKB—lung cancer	7.72e-06	0.00474	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CNDP2—lung cancer	7.26e-06	0.00445	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM2—lung cancer	7.26e-06	0.00445	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—HRAS—lung cancer	7.17e-06	0.0044	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	7.13e-06	0.00437	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTMR3—lung cancer	7.06e-06	0.00433	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	6.9e-06	0.00423	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PGAM1—lung cancer	6.88e-06	0.00422	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—ALB—lung cancer	6.65e-06	0.00408	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGB1—lung cancer	6.63e-06	0.00406	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2A7—lung cancer	6.57e-06	0.00403	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SDC4—lung cancer	6.43e-06	0.00394	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	6.25e-06	0.00383	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—RRM1—lung cancer	5.85e-06	0.00359	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA3—lung cancer	5.85e-06	0.00359	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	5.62e-06	0.00345	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	5.62e-06	0.00345	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—AVP—lung cancer	5.58e-06	0.00342	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—B4GALT5—lung cancer	5.5e-06	0.00337	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCB1—lung cancer	5.4e-06	0.00332	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA4—lung cancer	5.35e-06	0.00328	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	5.23e-06	0.00321	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA2—lung cancer	5.22e-06	0.0032	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MMP1—lung cancer	5.15e-06	0.00316	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA1—lung cancer	5.03e-06	0.00309	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCC3—lung cancer	4.98e-06	0.00305	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—APOA1—lung cancer	4.93e-06	0.00302	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKR1C1—lung cancer	4.82e-06	0.00296	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UGT1A1—lung cancer	4.68e-06	0.00287	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GNG11—lung cancer	4.51e-06	0.00277	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CG—lung cancer	4.5e-06	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—EGF—lung cancer	4.45e-06	0.00273	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	4.32e-06	0.00265	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDOA—lung cancer	4.3e-06	0.00263	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—APOA1—lung cancer	4.27e-06	0.00262	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CREBBP—lung cancer	4.17e-06	0.00256	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA3—lung cancer	4.17e-06	0.00256	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ADCY1—lung cancer	4.06e-06	0.00249	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCG2—lung cancer	4.06e-06	0.00249	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ENO2—lung cancer	3.98e-06	0.00244	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HPGDS—lung cancer	3.98e-06	0.00244	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CD—lung cancer	3.96e-06	0.00243	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPP2R1B—lung cancer	3.95e-06	0.00242	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALB—lung cancer	3.91e-06	0.0024	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTT1—lung cancer	3.86e-06	0.00237	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GCLC—lung cancer	3.81e-06	0.00234	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2A6—lung cancer	3.81e-06	0.00234	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	3.62e-06	0.00222	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ENO1—lung cancer	3.62e-06	0.00222	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.61e-06	0.00222	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAF1—lung cancer	3.53e-06	0.00217	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	3.51e-06	0.00215	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CB—lung cancer	3.45e-06	0.00212	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ALB—lung cancer	3.38e-06	0.00207	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2E1—lung cancer	3.24e-06	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NQO1—lung cancer	3.21e-06	0.00197	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IL2—lung cancer	3.17e-06	0.00194	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—RAF1—lung cancer	3.06e-06	0.00188	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—STK11—lung cancer	2.89e-06	0.00177	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—EP300—lung cancer	2.84e-06	0.00174	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	2.77e-06	0.0017	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SRC—lung cancer	2.76e-06	0.0017	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—lung cancer	2.69e-06	0.00165	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTP1—lung cancer	2.67e-06	0.00164	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NRAS—lung cancer	2.66e-06	0.00163	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CAT—lung cancer	2.6e-06	0.0016	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK3—lung cancer	2.55e-06	0.00156	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCB1—lung cancer	2.53e-06	0.00155	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TYMS—lung cancer	2.49e-06	0.00152	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—lung cancer	2.46e-06	0.00151	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.34e-06	0.00144	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1A1—lung cancer	2.33e-06	0.00143	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ERCC2—lung cancer	2.31e-06	0.00142	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—lung cancer	2.29e-06	0.0014	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	2.19e-06	0.00135	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—lung cancer	2.1e-06	0.00129	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—lung cancer	2.03e-06	0.00125	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APOA1—lung cancer	2e-06	0.00123	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.98e-06	0.00122	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HRAS—lung cancer	1.95e-06	0.00119	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CG—lung cancer	1.82e-06	0.00112	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—POMC—lung cancer	1.74e-06	0.00107	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT1—lung cancer	1.72e-06	0.00105	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CREBBP—lung cancer	1.69e-06	0.00104	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CD—lung cancer	1.6e-06	0.000984	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALB—lung cancer	1.58e-06	0.000971	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CB—lung cancer	1.4e-06	0.000858	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—lung cancer	1.39e-06	0.00085	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTEN—lung cancer	1.21e-06	0.000741	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—EP300—lung cancer	1.15e-06	0.000707	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—lung cancer	8.52e-07	0.000523	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKT1—lung cancer	6.96e-07	0.000427	CbGpPWpGaD
